Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

AXCEL METRONIDAZOLE-200 TABLETS 200 mg

Approval Number

SIN10509P

Drug Name

AXCEL METRONIDAZOLE-200 TABLETS 200 mg

Product Name

AXCEL METRONIDAZOLE-200 TABLETS 200 mg

Approval Date

December 5, 1998

Registrant

KOTRA PHARMA MARKETING

Licence Holder

KOTRA PHARMA MARKETING

Regulatory Information

Registrant

KOTRA PHARMA MARKETING

Licence Holder

KOTRA PHARMA MARKETING

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

J01XD01

ATC Item Name

metronidazole

Manufacturer Information

Pharmaceutical Manufacturer

KOTRA PHARMA MARKETING

Manufacturers

KOTRA PHARMA (M) SDN BHD

Active Ingredients

Ingredient Name

METRONIDAZOLE

Strength

200 mg

Drug MonographMetronidazole

Documents

Package Inserts

1.4.3 Proposed Package Insert - Clean (230922).pdf

Approved: September 27, 2022

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

AXCEL METRONIDAZOLE-200 TABLETS 200 mg - HSA Approval | MedPath